# Rajeev Mantri

> Rajeev Mantri is a seed investor at Navam Capital (Pune) backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Navam Capital](https://shizune.co/investors/profile/navam-capital)
- Location: Pune, India
- Total investments: 2
- Last investment: Nov 2010
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: http://in.linkedin.com/in/rmantri
- X (Twitter): http://twitter.com/RMantri

Rajeev Mantri is a seed investor at Navam Capital in Pune focused on Health Care and Biotechnology. Rajeev Mantri is Managing Director at Navam Capital. Rajeev is also Director at GPSK Investment Group, a proprietary trading and investment management firm active in India’s financial markets. Prior to founding Navam Capital, Rajeev worked at New York-based venture capital fund Lux Capital, focusing on investments in energy, water and advancedmaterials. Rajeev has been a columnist on technology, venture capital and entrepreneurship in India for Mint, The Wall Street Journal, Financial Times,

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vyome Therapeutics | Vyome Biosciences is an innovation driven company, with a vision to develop novel drugs for antibiotics-resistant acne and other opportunist pathogens through a unique pipeline of antibiotics that retard resistance development. Vyome Biosciences’ management team members are the leaders in the field, with deep expertise, demonstratedcapability and a proven track record of successfully launching over 50 products in dermatology & other life sciences areas, and building visionary companies. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The *lead molecule (VB 1953)*, which targets the huge unmet need in the drug resistant acne prescription market, will be entering the clinical phase with *USFDA IND Application Filing in Q4 2015*. Vyome has state-of-the-art infrastructure facilities to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace. | $1M | Seed | Nov 01, 2010 |  |
| EnNatura Technology Ventures | EnNatura Technology Ventures is a clean materials company that develops specialty chemicals from renewable sources. It designs polymers that reduce hydrocarbon consumption. The company also provides a resin platform for application in the printing ink industry as well as eco-friendly printing inks.EnNatura Technology Ventures was founded in 2006and is based in New Delhi, India. | $200K | Seed | Jan 07, 2010 |  |

2 of 2 investments shown.

## About Navam Capital

VC Fund · Calcutta Bagh Bazar, India

Navam Capital is an India-based venture capital firm focused on making seed and early-stage investments in Energy, Technology and Health Care.

2 contacts available at Navam Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Carl Barrelet | Venture Partner | https://shizune.co/investors/profile/carl-barrelet |
| Rajeev Mantri | Executive Director & Founder | https://shizune.co/investors/profile/rajeev-mantri |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Rajeev Mantri invest in?

Rajeev Mantri invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Rajeev Mantri last invest?

The most recent investment recorded for Rajeev Mantri closed in Nov 2010. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co